The American Philanthropic Ventures Association, a Houston non-profit organization, requests the honor of your presence at a breakfast meeting to introduce Greffex, Inc.
Greffex is a biotech company with a technology platform, moving toward clinical trials, which address the growing global need for pandemic-prevention vaccines dramatically faster and lower-cost than any vaccine on the market today.
Greffex is working with Texas A&M University’s Center for Innovation in Advanced Development and Manufacturing and the Texas A&M College of Veterinary Medicine.
Speakers:
Mr. John White
Former Chairman of the Board of Regents of Texas A&M University Systems
Mr. Harry Bushong
Convergence Ventures
Mr. John R. Price
Co-Chairman, President and Chief Executive Officer, Greffex, Inc.
Requested contribution $25.00
Please join us to learn more about Greffex.
Guests are welcome.
RSVP by November 11: 713-443-3662 or